$PRGO

PERRIGO Co plc (PRGO): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PERRIGO Co plc (PRGO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. prgo-20260630 0001585364 false 0001585364 2026-06-30 2026-06-30 0001585364 prgo:OrdinaryShares0001ParValueMember 2026-06-30 2026-06-30 0001585364 prgo:A4.900SeniorNoteDue2030Member 2026-06-30 2026-06-30 0001585364 prgo:A6.125SeniorNotesDue2032Member 2026-06-30 2026-06-30 00015853

Original reporting
Published Jun 30, 2026, 8:46 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$PRGO
Neutral
medium confidence
Mentioned
$PRGO
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PRGONeutralLow
01

Why it matters

The immediate tradable content is the governance change: two new board members, expanded board size, and committee assignments. There is no financial metric, guidance, or transaction disclosed.

02

Market read

Traders may monitor for follow-on announcements (strategy, CEO/CFO changes, or committee-driven reviews), but this filing alone is not a fundamental catalyst.

03

What to watch

The filing notes committee placements (Audit/Nominating/Governance; Talent/Compensation) but does not disclose compensation amounts or any operational mandate, limiting tradable implications.

Relevance 6/10Novelty 4/10Timing: after-hours / filed June 30, 2026 (8-K)

Background

This is an SEC Form 8-K (Item 5.02) reporting Perrigo’s director appointments and related compensatory arrangements, plus a Regulation FD press release reference.

Company-level read

Ticker impact

$PRGONeutralMedium confidence
Context

Perrigo’s Board appointed Salman Amin and Omer Gajial to the board effective June 30, 2026, expanding seats from 8 to 10.

Expected impact

Likely limited near-term price impact; any reaction would be sentiment/governance-driven rather than fundamentals.

Evidence & confidence

The filing is an SEC 8-K describing director appointments and committee assignments, with no earnings, guidance, deal, or regulatory outcome disclosed.

Market effects

Minor governance signal for consumer/health products; no sector-wide datapoint or policy change disclosed.

None indicated; filing is US-listed ADR/NYSE trading symbol PRGO.

None indicated; director bios reference global consumer/retail experience but no cross-border transaction is announced.

Counterpoint

Director appointments can be a precursor to strategic shifts, but this specific 8-K provides no stated strategy, so traders may be over-reading the signal.

Key entities

  • Perrigo Company plc

    Company filing the 8-K; appointed two directors effective June 30, 2026 and expanded board size from 8 to 10.

  • Salman Amin

    Appointed to Perrigo’s Board; will serve on the Audit Committee and Nominating and Governance Committee.

  • Omer Gajial

    Appointed to Perrigo’s Board; will serve on the Talent and Compensation Committee.

Related articles

$PRGOMedAI 8/10

Why is Perrigo stock surging today?

Investing.com reports Perrigo (PRGO) shares rose 24.4% to $13.41 after the company posted Q2 2026 results above analyst estimates. All-in adjusted diluted EPS was $0.50 versus $0.34 expected, and revenue was about $1.02B versus $1.01B. Perrigo cited cost savings and its Three-S strategy, reaffirmed 2026 EPS guidance, and said €305.6M from the Dermacosmetics sale will aid debt reduction.

$PRGOMed

PERRIGO Co plc (PRGO): Results of Operations and Financial Condition

PERRIGO Co plc (PRGO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cy26q2ex991pressrelease.htm EX-99.1 Document EXHIBIT 99.1 Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations • Execution of Three-S plan driving continued improvement in underlying business fundamentals, including market share growth in U.S

$PRGOMed

Perrigo Announces Leadership Transition

Perrigo Company plc (NYSE: PRGO) said its Board appointed Albert A. Manzone, a current director, as Interim President and CEO effective immediately, and launched a search for a permanent successor. Patrick Lockwood-Taylor resigned as President/CEO and from the Board, after the Board found certain personal conduct inconsistent with the company’s code of conduct. Perrigo reaffirmed its 2026 outlook: All In net sales growth of (5.5)% to (1.5)% and adjusted EPS of $2.00 to $2.30.

SK Hynix said to mull options for US$3 billion Chongqing plant

SK Hynix is considering options for its Chongqing, China semiconductor packaging and testing facility, including possibly bringing in an investor to accelerate growth. People familiar said a potential stake sale could value the plant at about US$3 billion and SK Hynix may keep a minority stake. Separately, it plans a 54 trillion won (US$38 billion) South Korea expansion for DRAM and NAND.

$ZGMed

Zillow Lays Off 500+ Employees Amid $4 Million Q2 Net Loss

Zillow Group said Aug. 4 it will cut more than 500 jobs, about 7% of staff, its second layoff round this year after 200 cuts in January. The company reported Q2 2026 revenue of $772 million, up 18% year over year, but a $4 million net loss driven by a $36 million restructuring charge, citing a flat housing market.